141 related articles for article (PubMed ID: 2518332)
1. Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group.
Parnetti L; Mecocci P; Petrini A; Longo A; Buccolieri A; Senin U
Neuropsychobiology; 1989; 22(2):97-100. PubMed ID: 2518332
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
Villardita C; Grioli S; Lomeo C; Cattaneo C; Parini J
Neuropsychobiology; 1992; 25(1):24-8. PubMed ID: 1603291
[TBL] [Abstract][Full Text] [Related]
3. Oxiracetam in dementia: a double-blind, placebo-controlled study.
Bottini G; Vallar G; Cappa S; Monza GC; Scarpini E; Baron P; Cheldi A; Scarlato G
Acta Neurol Scand; 1992 Sep; 86(3):237-41. PubMed ID: 1414239
[TBL] [Abstract][Full Text] [Related]
4. Oxiracetam in the treatment of multi-infarct dementia and primary degenerative dementia.
Dysken MW; Katz R; Stallone F; Kuskowski M
J Neuropsychiatry Clin Neurosci; 1989; 1(3):249-52. PubMed ID: 2521069
[TBL] [Abstract][Full Text] [Related]
5. Oxiracetam in the treatment of multi-infarct dementia.
Baumel B; Eisner L; Karukin M; MacNamara R; Katz RJ; Deveaugh-Geiss J
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):673-82. PubMed ID: 2781039
[TBL] [Abstract][Full Text] [Related]
6. Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study.
Maina G; Fiori L; Torta R; Fagiani MB; Ravizza L; Bonavita E; Ghiazza B; Teruzzi F; Zagnoni PG; Ferrario E
Neuropsychobiology; 1989; 21(3):141-5. PubMed ID: 2693996
[TBL] [Abstract][Full Text] [Related]
7. Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementia.
Villardita C; Parini J; Grioli S; Quattropani M; Lomeo C; Scapagnini U
J Neural Transm Suppl; 1987; 24():293-8. PubMed ID: 3479527
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy.
Rozzini R; Zanetti O; Bianchetti A
Acta Neurol (Napoli); 1993 Feb; 15(1):44-52. PubMed ID: 8456595
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of oxiracetam therapy in the treatment of cognitive deficiencies secondary to primary degenerative dementia.
Rozzini R; Zanetti O; Bianchetti A
Acta Neurol (Napoli); 1992 Apr; 14(2):117-26. PubMed ID: 1414555
[TBL] [Abstract][Full Text] [Related]
10. Selegiline versus oxiracetam in patients with Alzheimer-type dementia.
Falsaperla A; Monici Preti PA; Oliani C
Clin Ther; 1990; 12(5):376-84. PubMed ID: 2125242
[TBL] [Abstract][Full Text] [Related]
11. Patterns of neuropsychological functioning among patients with multi-infarct and Alzheimer's dementia: a comparative analysis.
Erker GJ; Searight HR; Peterson P
Int Psychogeriatr; 1995; 7(3):393-406. PubMed ID: 8821347
[TBL] [Abstract][Full Text] [Related]
12. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
[TBL] [Abstract][Full Text] [Related]
13. Visual association test to detect early dementia of the Alzheimer type.
Lindeboom J; Schmand B; Tulner L; Walstra G; Jonker C
J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):126-33. PubMed ID: 12122168
[TBL] [Abstract][Full Text] [Related]
14. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
[TBL] [Abstract][Full Text] [Related]
15. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
Kanowski S; Hoerr R
Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and differential diagnosis of multi-infarct dementia and Alzheimer's disease].
Jura E
Neurol Neurochir Pol; 1992; 26(1):9-18. PubMed ID: 1528370
[TBL] [Abstract][Full Text] [Related]
18. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
[TBL] [Abstract][Full Text] [Related]
19. Jian Nao Ning for treatment of memory impairment in patients with mild or moderate multi-infarct dementia.
Tian J; Yin J; Liu H; Yang C; Wang Y
J Tradit Chin Med; 2002 Dec; 22(4):247-51. PubMed ID: 16579082
[TBL] [Abstract][Full Text] [Related]
20. [Neuropsychological comparison between dementia of Alzheimer type and multiple subcortical infarction by easily applicable test battery].
Tei H; Miyazaki A; Iwata M
Rinsho Shinkeigaku; 1995 Nov; 35(11):1205-9. PubMed ID: 8720329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
